Knudsen BS - Search Results

1

Prostate cancer and the met hepatocyte growth factor receptor.

Knudsen BS, Edlund M. Knudsen BS, et al. Adv Cancer Res. 2004;91:31-67. doi: 10.1016/S0065-230X(04)91002-0. Adv Cancer Res. 2004. PMID: 15327888 Review.

2

Mechanisms of prostate cancer initiation and progression.

Knudsen BS, Vasioukhin V. Knudsen BS, et al. Adv Cancer Res. 2010;109:1-50. doi: 10.1016/B978-0-12-380890-5.00001-6. Adv Cancer Res. 2010. PMID: 21070913 Review.

3

The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms.

Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S, Nelson PS. Bavik C, et al. Cancer Res. 2006 Jan 15;66(2):794-802. doi: 10.1158/0008-5472.CAN-05-1716. Cancer Res. 2006. PMID: 16424011

4

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.

Mostaghel EA, Page ST, Lin DW, Fazli L, Coleman IM, True LD, Knudsen B, Hess DL, Nelson CC, Matsumoto AM, Bremner WJ, Gleave ME, Nelson PS. Mostaghel EA, et al. Cancer Res. 2007 May 15;67(10):5033-41. doi: 10.1158/0008-5472.CAN-06-3332. Cancer Res. 2007. PMID: 17510436 Clinical Trial.

5

Showering c-MET-dependent cancers with drugs.

Knudsen BS, Vande Woude G. Knudsen BS, et al. Curr Opin Genet Dev. 2008 Feb;18(1):87-96. doi: 10.1016/j.gde.2008.02.001. Epub 2008 Apr 9. Curr Opin Genet Dev. 2008. PMID: 18406132 Review.

6

The impact of cell adhesion changes on proliferation and survival during prostate cancer development and progression.

Knudsen BS, Miranti CK. Knudsen BS, et al. J Cell Biochem. 2006 Oct 1;99(2):345-61. doi: 10.1002/jcb.20934. J Cell Biochem. 2006. PMID: 16676354 Review.

7

Regulation of hepatocyte activator inhibitor-1 expression by androgen and oncogenic transformation in the prostate.

Knudsen BS, Lucas JM, Fazli L, Hawley S, Falcon S, Coleman IM, Martin DB, Xu C, True LD, Gleave ME, Nelson PS, Ayala GE. Knudsen BS, et al. Am J Pathol. 2005 Jul;167(1):255-66. doi: 10.1016/S0002-9440(10)62970-7. Am J Pathol. 2005. PMID: 15972969 Free PMC article.

8

Loss of stearoyl-CoA desaturase expression is a frequent event in prostate carcinoma.

Moore S, Knudsen B, True LD, Hawley S, Etzioni R, Wade C, Gifford D, Coleman I, Nelson PS. Moore S, et al. Int J Cancer. 2005 Apr 20;114(4):563-71. doi: 10.1002/ijc.20773. Int J Cancer. 2005. PMID: 15609334 Free article.

9

A molecular correlate to the Gleason grading system for prostate adenocarcinoma.

True L, Coleman I, Hawley S, Huang CY, Gifford D, Coleman R, Beer TM, Gelmann E, Datta M, Mostaghel E, Knudsen B, Lange P, Vessella R, Lin D, Hood L, Nelson PS. True L, et al. Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10991-6. doi: 10.1073/pnas.0603678103. Epub 2006 Jul 7. Proc Natl Acad Sci U S A. 2006. PMID: 16829574 Free PMC article.

10

ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis.

Rotinen M, You S, Yang J, Coetzee SG, Reis-Sobreiro M, Huang WC, Huang F, Pan X, Yáñez A, Hazelett DJ, Chu CY, Steadman K, Morrissey CM, Nelson PS, Corey E, Chung LWK, Freedland SJ, Di Vizio D, Garraway IP, Murali R, Knudsen BS, Freeman MR. Rotinen M, et al. Among authors: knudsen bs. Nat Med. 2018 Dec;24(12):1887-1898. doi: 10.1038/s41591-018-0241-1. Epub 2018 Nov 26. Nat Med. 2018. PMID: 30478421 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page